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Abstract The aimofthispartofthe FinEsS-studieswas to assesswhetherdifferencesexistedinprevalence of asthma,
chronic bronchitis, and respiratory symptoms between three Baltic capitals, and to examine risk factor profiles for re-
spiratoryconditions.In1996, a postal surveywasperformedinthese citieswith a responserate of 72% in Stockholm,76%
inHelsinki, and 68% inTallinn.Theprevalence ofphysician-diagnosedasthmawas 7.6% in Stockholm,6.2% inHelsinki, and
2.3% inTallinn, while respiratory symptomsweremostcommoninTallinn.The prevalence of physician-diagnosed chronic
bronchitis was 10.6% inTallinn, 3.4% in Helsinki, and 3.0% in Stockholm.Risk factor analyses revealed a significantly in-
creased risk for those living inTallinn compared to that of Stockholm for wheezing conditions,OR1.56–1.69, longstanding
cough,OR1.92 (1.74–2.13), attacks of shortness of breath during the previous12 months,OR1.35 (1.20–1.52), and chronic
productive cough,OR1.49 (1.28–1.74). Subjects having symptoms common in asthmaweremore likely to have physician-
diagnosed asthma in Stockholm and Helsinki than inTallinn, while subjects having bronchitis symptoms hadmore often
physician-diagnosed chronic bronchitis inTallinn.Prevalence of respiratory symptomswas higher inTallinn than in Stock-
holm and Helsinki, while physician-diagnosed asthmawasmore common in Stockholm and Helsinki.The prevalence of
physician-diagnosed chronic bronchitis was three times as high inTallinn as in Helsinki or Stockholm.Our results also
suggest large differences in diagnostic practices betweenthe three countries, while the differences betweenthecapitals
in true prevalence of diseasemaybe small.r2002 Elsevier Science Ltd.Allrights reserved.
doi:10.1053/rmed.2002.1308, available online at http://www.idealibrary.comon
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Asthma and type-1allergy in children are reported to be
moreprevalent inWestern than in Eastern Europe (1–10).
Type-1 allergy is also more common in Western urban
areas than in rural environments (7,8,11). Furthermore,
bothhigher (1,4) and lower (7) prevalence rates for bron-
chial hyperresponsiveness among children have been re-
ported inWestern than in Eastern Europe.
Respiratory symptoms, bronchial hyperresponsive-
ness, and atopic sensitization among adults havebeen re-
ported to be more prevalent in the former West
Germany than in the former East Germany (12,13). InReceived 30October 2001, accepted in revised form 5 February 2002.
Correspondence shouldbe addressed to: Paula Pallasaho,MD,HUSP.O.
box160/2 FIN-00029 Helsinki, Finland.Fax:+358 9 7557672; E-mail:
paula.pallasaho@¢mnet.¢the European Community Respiratory Health Survey
(ECRHS), the prevalence of asthmawas 2.1% in Erfurt in
the former East Germany, and 4.4% in Hamburg (14).
Comparisons betweenTartu, Estonia, and Uppsala, Swe-
den, showedrespiratory symptoms to bemore common
in Tartu, with prevalence of asthma attacks, hay fever,
and type-1allergymore common in Uppsala (15,16).
These studies indicate the prevalence of asthma in
children and young adults only.Whether this di¡erence
is true also for the middle-aged and elderly remains un-
known. As for chronic bronchitis and chronic obstruc-
tive pulmonary disease (COPD), these are more
common in Eastern Europe than in Western Europe
(17–21).
We have compared prevalence rates of respiratory
symptoms and self-reported disease in three Baltic capi-
tals, Stockholm (Sweden), Helsinki (Finland), and Tallinn
760 RESPIRATORYMEDICINE(Estonia) to evaluate di¡erences both in diagnostic tradi-
tions and in prevalence of respiratory symptoms, and to
compare risk factor patterns for respiratory conditions
in these cities. The situation in Eastern European coun-
tries changes rapidly.This study was performed in 1996,
only a few years after the desolation of the former So-
viet Union, before any major changes in the health-care
system, lifestyle, or airborne exposure had occurred in
Estonia.
MATERIALANDMETHODS
Study areas andpopulation
The study is part of the FinEsS-study in progress in Fin-
land, Estonia, and Sweden, aiming to assess prevalence
rates and risk factors for airway disorders. A postal
questionnaire was sent in 1996 to randomly selected in-
dividuals in the three capitals, with data analysed from
subjects aged 20–64 years. Complete responses came
from 5335 subjects in Stockholm (response rate 72%),
5671in Helsinki (76%), and 7735 inTallinn (68%), as a total
of18 741 (Table1).
Questionnaire
The questionnaires were identical, and were in each
country’s native languages. The questions were
translated from English to Swedish, Finnish, Estonian,
and Russian, and then back to English.The questionnaire
was developed from a widely used questionnaire in
the Nordic countries (22), which was originally devel-
oped from the British Medical Research Council‘s
questionnaire (23) and has been previously described in
detail (24).
De¢nitions
Asthma and chronic bronchitis were classi¢ed into two
ways:Thosewho answered ‘‘yes’’ to the questions: ‘‘Have
you been diagnosed as having asthma by a doctor?’’ or
‘‘Have you been diagnosed as having chronic bronchitis
or emphysema by a doctor?’’ were classi¢ed as having
physician-diagnosed asthma or physician-diagnosedchronic
bronchitis.Those who answered ‘‘yes’’ to: ‘‘Have you ever
had asthma?’’or ‘‘Haveyou ever had chronic bronchitis or
emphysema?’’ were called as ever asthma or ever chronic
bronchitis.
Any wheezeF‘‘Have you hadwheezing or whistling in
your chest at any time during the last12 months?’’
Recurrent wheeze F ‘‘Have you had wheezing, whis-
tling, or a noisy sound in your chest when breathing?’’
Wheezing with shortness of breath apart from coldsF
‘‘yes’’ to the question about any wheeze, and ‘‘yes’’ to the
two questions: ‘‘Haveyoubeen at allbreathlesswhen the
wheezing noise was present?’’ and ‘‘Have you had thiswheezing or whistling when you did not have a cold?’’
Thesewere ¢rst used in the IUATLD questionnaire (25).
CurrentasthmaFphysician-diagnosed asthma, anduse
of asthma medication, or attacks of shortness of breath
during the previous12 months, or wheezing.
Chronic productive coughFsputum production on
mostdays during periods of at least 3months in two suc-
cessive years.
Analyses
The chi-square test was used for uni- and bi-variate
comparisons and one way ANOVA for testing for
trends.Mantel–Haenszel test was used to calculate pre-
valence rates standardizedby age and smoking according
to the data of Helsinki.Multiple logistic regression analy-
sis was performed in order to estimate e¡ects of di¡er-
ent independent variables on bronchitis and asthma
symptoms. As independent variables in logistic regres-
sion instead of asthma we have used the combination of
symptoms from IUATLD (25): wheezing with shortness
of breath apart from colds during the previous 12
months, which also has been used in ECRHS (14). Instead
of chronic bronchitis, we have used chronic productive
cough, which is close to the CIBA de¢nition for chronic
bronchitis (26). Statistical analyses were performed
by use of the Statistical Package for the Social Sciences
(SPSS) at the National Institute for Working Life in
Sweden.
RESULTS
Participation rates and smoking
The participation rate was highest in Helsinki, 69%
for men, and 82% for women. It was, overall, higher
among women than men, with the highest participation
occurring in subjects of both sexes, aged 50 or older
(Table1).
Smoking habits by gender and area are presented in
Table 1 and Fig. 1. Current smoking and smoking more
than14 cigarettes daily weremost common inTallinn for
men of all ages. The prevalence of current smokers
amongmen aged 20–49 was more than 60% inTallinn. In
women over 40, current smoking was most common in
Stockholm, while younger women most often were cur-
rent smokers inTallinn. In contrast toHelsinki andTallinn,
current smokingwasmore common amongwomen than
men under 50 in Stockholm. The prevalence of current
smokers was overall lowest among subjects 60–64. Dif-
ferences in smoking habits were signi¢cant when com-
paringTallinn to Stockholm or Helsinki, (Po0.001), while
Stockholm data did not di¡er signi¢cantly from that of
Helsinki’s.
TABLE 1. Studypopulationby age andgender
20–29 years 30–39 years 40–49 years 50–59 years 60–64 years Total
Women Men Women Men Women Men Women Men Women Men Women Men
Stockholm
Study sample 953 884 1,033 1101 814 838 693 661 239 237 3,732 3721
Participants 732 590 766 711 620 533 543 472 190 178 2851 2484
Response rate (%) 77 67 74 65 76 64 78 71 79 75 76 67
Smokers (%) 34 32 32 29 36 35 33 37 23 24 33 32
Ex-smokers (%) 10 7 18 14 21 22 26 29 22 36 19 18
Helsinki
Study sample 920 827 1039 994 978 873 772 652 260 223 3969 3515
Participants 760 506 832 656 787 599 647 490 216 178 3242 2429
Response rate (%) 83 61 80 66 80 69 84 75 83 80 82 69
Smokers (%) 35 40 34 43 32 34 24 38 18 26 31 38
Ex-smokers (%) 8 9 12 13 19 26 19 31 15 35 14 21
Tallinn
Study sample 1,273 1,218 1,428 1243 1535 1269 1,342 1042 568 398 6,146 5170
Participants 901 767 948 695 1,108 784 1012 643 519 358 4488 3247
Response rate (%) 71 63 66 56 72 62 75 62 91 90 73 63
Smokers (%) 42 62 41 66 35 61 20 47 11 37 31 57
Ex-smokers (%) 8 6 11 11 12 16 8 23 5 27 9 15
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FIG. 1. Prevalence (%) of current smoking (a) and smoking more than 14 cigarettes daily (b) by gender in Stockholm,Helsinki, and
Tallinn.
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Prevalence rates for respiratory symptoms by area and
gender are shown inTable 2. Any wheeze during the pre-
vious12 months and recurrent wheeze were most com-
mon in Tallinn for both genders. The prevalences of
wheezing with attacks of shortness of breath apart from
colds and recurrent wheezewere similar in Helsinki and
in Stockholm, 6F8% in both, while any wheeze during
the previous 12 months was more common in Helsinki(20%) than in Stockholm (16%). All di¡erences in asth-
ma-related symptoms between the areas were signi¢-
cant (Po0.001).
Longstanding cough and sputum production were
most prevalent in Tallinn, with chronic productive
cough most prevalent in Helsinki. Stockholm had the
lowest prevalence rates of dyspnea and bronchitis symp-
toms. As for asthma-related symptoms, a signi¢cant dif-
ference (Po0.001) existed in prevalence rates for
the bronchitis symptoms among the three cities. Stan-
TABLE 2. Prevalence rates (%) of respiratory symptoms, ever asthma, physician-diagnosed asthma, physician-diagnosed chronic bronchitis, and use of asthmamedication in Stock-
holm (S),Helsinki (H), and Tallinn (T)
Men Women Total Di¡erence by
S H T S H T S H T Age Gender Area Smoking
Attacks of SOB duringprevious12 months 9.4 10.7 13.0 12.0 14.2 12.9 10.8 (10.7) 12.7 (12.7) 12.9 (12.1) o0.001 o0.001 o0.001 o0.001
Anywheeze 15.1 21.3 23.1 16.8 18.9 20.0 16.0 (16.2) 19.9 (21.0) 21.3 (20.1) 0.002 0.036 o0.001 o0.001
Recurrentwheeze 7.9 7.8 14.1 8.6 6.3 11.3 8.3 (8.5) 7.0 (7.1) 12.5 (11.3) o0.001 0.003 o0.001 o0.001
Wheezingwith SOB apart fromcolds 5.7 7.2 5.0 6.6 7.5 3.9 6.2 (6.2) 7.3 (7.5) 4.4 (4.2) 0.008 0.749 o0.001 o0.001
Ever asthma 8.2 5.6 2.9 9.1 7.7 3.0 8.7 (9.2) 6.8 (6.9) 3.0 (3.1) 0.230 0.012 o0.001 0.041
Physician-diagnosed asthma 6.9 5.1 2.5 8.2 7.0 2.1 7.6 (7.7) 6.2 (6.2) 2.3 (2.3) o0.001 0.017 o0.001 0.536
Use of asthmamedication 7.3 4.2 2.2 9.3 6.6 2.4 8.4 (8.3) 5.6 (5.7) 2.3 (2.3) o0.001 o0.001 o0.001 0.537
Physician-diagnosed chronic bronchitis 2.5 3.6 9.7 3.4 3.2 11.3 3.0 (3.0) 3.4 (3.4) 10.6 (10.1) 0.002 0.037 o0.001 0.323
Longstandingcough 12.5 18.0 22.6 15.4 21.0 26.8 14.1 (14.6) 19.7 (20.1) 25.1 (24.4) o0.001 o0.001 o0.001 o0.001
Sputumproduction 15.6 25.4 29.2 15.9 27.0 29.6 15.8 (16.1) 26.3 (27.2) 29.4 (28.6) 0.001 0.034 o0.001 o0.001
Chronic productive cough 5.4 12.2 10.2 5.7 11.4 8.0 5.6 (5.6) 11.7 (12.1) 8.9 (8.4) o0.001 0.033 o0.001 o0.001
Note: SOB=shortness of breath.Di¡erences (P-values) by age, gender, area, and smokinghabits.Prevalence rates standardizedby age and smoking inparentheses.
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764 RESPIRATORYMEDICINEdardization by age and smoking changed the ¢gures
only slightly.
Asthma and chronic bronchitis
Physician-diagnosed asthma was reported by 7.6% in
Stockholm, by 6.2% inHelsinki, andby 2.3% inTallinn (Ta-
ble 2). ‘‘Current asthma’’ was also most prevalent in
Stockholm, 6.8% vs 5.7% in Helsinki, and 2.1% inTallinn.
Furthermore, use of asthma medicationwasmost com-
mon in Stockholm.Di¡erences in prevalence of the asth-
ma categories between the cities were signi¢cant
(Po0.001), and asthma was more common among wo-
men. A three- to fourfold higher proportion of subjects
having any wheeze, recurrent wheeze, attacks of short-
ness of breath, or wheezing with shortness of breath
apart from colds had a physician-diagnosed asthma in
Helsinki and Stockholm than inTallinn (Po0.001) (Fig. 2).
Among subjects with asthma symptoms, a greater pro-
portionwas diagnosedwith asthma in Stockholm than in
Helsinki, with a signi¢cant di¡erence (Po0.01) except for
wheezing with shortness of breath apart from colds.
The prevalence of physician-diagnosed chronic bron-
chitis was considerably lower than the prevalence of
chronic productive cough in Stockholm and Helsinki,
while the opposite was found in Tallinn. Physician-diag-
nosed chronic bronchitis was reported by 3.0% in Stock-
holm, 3.4% inHelsinki, and10.6% inTallinn (Po0.001,Table
2).These subjects with bronchitis symptoms were more
often diagnosed as having chronic bronchitis in TallinnAny wheeze
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FIG. 2. Prevalence (%) of physician-diagnosed asthma among sub
breath (SOB) during the previous12 months, or wheezingwith atta
and Tallinn.than inHelsinki and Stockholm (Po0.001) (Fig. 3).Thedif-
ference between Stockholm and Helsinki was signi¢cant
only for recurrent wheeze, Po0.05.
Multivariate relationships
Signi¢cant risk factors for chronic productive cough
were smoking 5–14 cigarettes daily, OR1.80; smoking 15
ormore cigarettes daily,OR 3.78; having a family history
of chronic bronchitis,OR2.91; and livingeither inHelsinki
orTallinn vs Stockholm.The risk of having a chronic pro-
ductive cough increased with age (Table 3).The risk fac-
tors for longstanding cough were similar to but lower
than for chronic productive cough. In addition, long-
standing cough was associated with female gender, OR
1.4.
Smoking as a risk factor for wheezing conditions and
for attacks of shortness ofbreath increasedwith increas-
ing number of cigarettes consumed. A family history of
asthma,OR 2.17–2.77, and age 60–64,OR1.30–2.29, were
signi¢cantrisk factors for wheezing conditions, or for at-
tacks of shortness of breath, while gender had no large
impact. Living inTallinn was a signi¢cant risk factor for
recurrentwheeze, any wheeze, and attacks of shortness
of breath during the previous 12 months, OR 1.35–1.56
(Table 3).
The risk-factor pro¢les for wheezing conditions and
chronic productive cough by area are presented inTable
4. Smokingmore than14 cigarettes daily was a signi¢cant
risk factor for all the respiratory conditions in the threecks of
ness of
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FIG. 3. Prevalence (%) of physician-diagnosed chronic bronchitis among subjects with sputum production, longstanding cough,
chronic productive cough, or recurrentwheeze in Stockholm,Helsinki, and Tallinn.
PREVALENCEOFRESPIRATORYSYMPTOMSINBALTICCAPITALS 765cities,OR 2.21–5.77. A family history of asthmawas a sig-
ni¢cantrisk factor for thewheezing conditions,OR 2.12–
3.12, regardless of the area. A family history of obstruc-
tive airway disease was a signi¢cant risk factor for
chronic bronchitis,OR1.73–2.67. Age 60–64was a signi¢-
cant risk factor for all the respiratory conditions inTal-
linn, and except for any wheeze, in Helsinki; while in
Stockholm, age 60–64 was a signi¢cant risk factor only
for recurrent wheeze (Table 4).
DISCUSSION
The prevalence of type-1 allergy has been documented
to be higher in theWest among both children and young
adults (1,7–9,12,13,16).The majority of studies have shown
asthma to bemore common in theWest (1–7), although
many studies ¢nd no major di¡erences in prevalence of
respiratory symptoms (7,8), or ¢nd prevalence rates
higher in the East (1,5,7,15). Do real di¡erences exist in
the prevalence rates for asthma in adults? Has only aller-
gic asthma been more common inWestern Europe? An
increasing prevalence of hay fever and atopy in children,
but not of asthma, have been shown in former East Ger-
many after changes towards a western lifestyle (4,6). A
large proportion of respiratory symptoms may be
causedbynonallergic asthma in Eastern Europe,because
the diagnosis of asthmahasrequiredallergic sensitization
in the former Soviet Union, a practice which in£uenced
Estonians (10). To summarize, if type-1 allergy is more
frequent inWestern Europe, this would suggest allergicasthma to be more common inWestern Europe as well.
Regarding the total impactof asthma,wehave to consid-
er that the results available are somewhatdivergent, and
a critical review of the literature o¡ers contradictory
data.
Several factors have contributed to the validity of our
results. Although conducted in 1996, the study took
place in the same year and same season in all three capi-
tals.The participation rates were all satisfactory, making
the results quite representative. A nonresponder study
was performed in the study centers ofNorthern Finland
andNorthern Sweden.Youngmenweremost often non-
responders in those centers as in the centers reported in
this paper. The prevalence of symptoms among nonre-
sponders did not di¡er signi¢cantly from symptoms re-
ported by thosewho participated originally (27).
In our study, symptoms common to asthma were in
general highest in Tallinn and lowest in Stockholm,
whereas the prevalence of ever asthma and physician-di-
agnosed asthmawere highest in Stockholm and lowest in
Tallinn.This raises the questionwhether di¡erences in di-
agnostic practices may explain this discrepancy. Analyz-
ing the proportion of those having asthma diagnosed by
a physician among subjects reporting symptoms com-
mon in asthma showed that subjects with these symp-
toms most likely had physician-diagnosed asthma in
Stockholm, while inTallinn a considerably lower propor-
tion of such subjects were diagnosed as having asthma.
The result of the risk factor analysis was concordant
with these prevalence rates. Consequently, the highest
risk for recurrent wheeze, any wheeze, and attacks of
TABLE 3. Risk factors (OR) for longstanding cough, chronic productive cough, recurrent wheeze, attacks of shortness of breath (SOB) during previous12 months, any wheeze, and
wheezingwith shortness of breath apart fromcolds duringprevious12 months calculatedbymultiple logistic regression analysis
Independent variables Dependent variables
Longstanding
cough
Chronic productive
cough
Recurrent
wheeze
Attacks of
SOB
Anywheeze Wheezingwith SOB
apart fromcolds
Variables Categories OR 95% Cl OR 95% Cl OR 95% Cl OR 95% Cl OR 95% Cl OR 95% Cl
Sex Male 1 1 1 1 1 1
Female 1.4 1.29–1.52 1.05 0.94–1.18 1.03 0.93–1.15 1.24 1.13–1.37 1.09 1.01–1.18 1.06 0.93–1.21
Age (year) 20–29 1 1 1 1 1 1
30–39 0.9 0.80–1.01 1.07 0.90–1.28 1.05 0.89–1.24 0.87 0.76–0.99 0.89 0.80–0.99 0.92 0.76–1.12
40–49 1 0.89–1.12 1.36 1.15–1.62 1.37 1.17–1.61 1.04 0.91–1.19 0.89 0.80–1.00 1.09 0.90–1.32
50–59 1.01 0.90–1.14 1.53 1.28–1.82 1.40 1.19–1.65 0.94 0.81–1.08 0.93 0.83–1.04 1.10 0.90–1.34
60–64 1.26 1.09–1.46 2.14 1.75–2.62 2.29 1.90–2.77 1.38 1.17–1.63 1.30 1.13–1.49 1.58 1.25–1.99
Familyhistoryof asthma No 1 1 1 1
Yes 2.61 2.31–2.95 2.77 2.50–3.08 2.17 1.98–2.39 2.54 2.20–2.93
Familyhistoryof chronic No 1 1
bronchitis or emphysema Yes 2.84 2.54–3.16 2.91 2.53–3.34
Smokinghabits Nonsmokers 1 1 1 1
Ex-smokers 1.05 0.93–1.18 1.18 0.99–1.40 1.23 1.03–1.46 1.27 1.11–1.46 1.25 1.11–1.40 1.41 1.17–1.71
Smokingo5 cig 1.11 0.96–1.29 1.19 0.95–1.50 1.45 1.17–1.79 1.21 1.02–1.44 1.44 1.25–1.66 1.28 1.00–1.65
Smoking 5–14 cig 1.47 1.80 1.53–2.10 2.59 2.24–2.99 1.42 1.25–1.62 2.28 2.06–2.53 1.53 1.27–1.85
Smokingo14 cig 2.34 3.78 3.27–4.37 4.28 3.71–4.93 1.86 1.63–2.12 3.73 3.35–4.15 2.6 2.18–3.09
City Stockholm 1 1 1 1 1 1
Helsinki 1.51 1.35–1.68 2.38 2.04–2.78 0.81 0.70–0.94 1.23 1.09–1.39 1.35 1.22–1.49 1.22 1.05–1.43
Tallinn 1.92 1.74–2.13 1.49 1.28–1.74 1.69 1.49–1.93 1.35 1.20–1.52 1.56 1.41–1.71 0.74 0.63–0.88
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TABLE 4. Risk factors (OR) for chronic productive cough, recurrentwheeze, any wheeze, andwheezingwith shortness of breath (SOB) apart fromcolds in Stockholm (S),Helsinki
(H) and Tallinn (T) calculated bymultiple logistic regression analysis.Nonsigni¢cant values are inparentheses
Independent variables Dependent variables
Chronic productive cough Recurrentwheeze Anywheeze Wheezingwith SOB
Variables Categories S H T S H T S H T S H T
Age 20–29 1 1 1 1 1 1 1 1 1 1 1 1
60–64 (1.38) 2.88 2.21 2.14 2.31 2.45 (1.04) (0.93) 1.79 (1.22) 1.68 2.07
Gender Male 1 1 1 1 1 1 1 1 1 1 1 1
Female (1.12) (1.08) (0.96) (1.03) (0.89) (1.12) (1.05) (0.99) 1.22 (1.12) (1.13) (0.95)
Familyhistoryof asthma No 1 1 1 1 1 1 1 1 1
Yes 3.12 2.91 2.15 2.37 2.12 2.07 2.70 2.46 2.45
Familyhistoryof obstructive No 1 1 1
airways disease Yes 2.05 1.73 2.67
Smokinghabits Non-smokers 1 1 1 1 1 1 1 1 1 1 1 1
Smoking414 cigarettes/day 2.69 4.64 3.36 3.15 5.77 4.43 2.92 4.58 4.05 2.21 3.09 2.50
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768 RESPIRATORYMEDICINEshortness of breath was found for those living inTallinn.
Generally, the prevalence of asthma in Stockholm and
Helsinki was close to prevalence rates found more re-
cently in Northern Sweden (28) and in Norway (29).
Prevalence rates for chronic bronchitis and COPD
have been higher in Eastern than in Western Europe
(17–21). In this study, the prevalence of single bronchitis
symptoms was highest in Tallinn, the prevalences of
chronic productive cough were similar in Tallinn and in
Helsinki, but lower in Stockholm. However, the preva-
lence for physician-diagnosed chronic bronchitis was ap-
proximately three times as high inTallinn as compared to
either Stockholm or Helsinki. Assessing diagnostic man-
ners in this respect, we could notice that subjects re-
porting symptoms related to chronic bronchitis were
most likely to have physician-diagnosed chronic bronchi-
tis inTallinn,while theseproportionsweremuch lower in
Stockholm and Helsinki. Current smoking and heavy
smoking were most prevalent in Tallinn among men,
whichmay in partexplain thehighprevalence of bronchi-
tis symptoms in Tallinn. Di¡erent diagnostic traditions
have probably also contributed to the higher prevalence
of chronic bronchitis inTallinn than in Stockholm or Hel-
sinki.
Risk factor analyses revealed that heavy smoking and
having a family history of obstructive airways disease
were the major risk factors for respiratory symptoms
with no consistent in£uence of gender. An interesting
¢nding was that the risk factor pattern was similar in
the three areas, although in£uence of age on symptoms
was most pronounced inTallinn, whereas increasing age
generally had less e¡ect in Stockholm than in the other
cities.
In conclusion, we found that most respiratory symp-
toms, both symptoms associated with asthma or with
chronic bronchitis, weremore common inTallinn than in
Stockholm or Helsinki. However, the prevalence of phy-
sician-diagnosed asthma was considerably lower in Tal-
linn. Subjects with symptoms common to asthma were
more likely to have physician-diagnosed asthma in Stock-
holm andHelsinki than inTallinn.This suggests a large dif-
ference in diagnostic practices, which to a large extent
could explain the considerable di¡erences in prevalence
rates of physician-diagnosed asthma between the capi-
tals of Sweden, Finland, and Estonia.On the other hand,
subjects reporting respiratory symptoms commonly ob-
served in chronic bronchitis were more likely to have
physician-diagnosed chronic bronchitis inTallinn than in
Stockholm or Helsinki.
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